posted on 2024-01-25, 01:07authored byJesse Gordon-Blake, Kiira Ratia, Victoria Weidig, Ganga Reddy Velma, Martha Ackerman-Berrier, Christopher Penton, Soumya Reddy Musku, Erick T.M. Alves, Tom Driver, Leon Tai, Gregory R. J. Thatcher
Evidence supports boosting nicotinamide adenine dinucleotide
(NAD+) to counteract oxidative stress in aging and neurodegenerative
disease. One approach is to enhance the activity of nicotinamide phosphoribosyltransferase
(NAMPT). Novel NAMPT positive allosteric modulators (N-PAMs) were
identified. A cocrystal structure confirmed N-PAM binding to the NAMPT
rear channel. Early hit-to-lead efforts led to a 1.88-fold maximum
increase in the level of NAD+ in human THP-1 cells. Select
N-PAMs were assessed for mitigation of reactive oxygen species (ROS)
in HT-22 neuronal cells subject to inflammatory stress using tumor
necrosis factor alpha (TNFα). N-PAMs that increased NAD+ more effectively in THP-1 cells attenuated TNFα-induced
ROS more effectively in HT-22 cells. The most efficacious N-PAM completely
attenuated ROS elevation in glutamate-stressed HT-22 cells, a model
of neuronal excitotoxicity. This work demonstrates for the first time
that N-PAMs are capable of mitigating elevated ROS in neurons stressed
with TNFα and glutamate and provides support for further N-PAM
optimization for treatment of neurodegenerative diseases.